In accordance with our results, phase I clinical trials with split H5N1 vaccine or a vaccinia virus-based universal influenza vaccine candidate have also shown a prevalence of effector memory over central memory CD4+ T cell responses [48]. This evidence concerns the gene CD4 and influenza.